Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
About This Webinar

Mary Ann Liebert Inc. is the proud publisher of groundbreaking, peer-reviewed journals including Human Gene Therapy and The CRISPR Journal, providing all-inclusive coverage of the research, developments, and novel technologies that are driving today's explosion of gene therapy advances. Its flagship trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and remains the key driver in the growth of the industry, paving the way for the development of new technologies and applications, and  investment and career opportunities.

Language: English
Who can attend? Everyone
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts Mary Ann Liebert, Inc: See What’s New from Human Gene Therapy and GEN
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents